Drug Enforcement Administration December 29, 2017 – Federal Register Recent Federal Regulation Documents

Bulk Manufacturer of Controlled Substances Application: AMPAC Fine Chemicals LLC
Document Number: 2017-28178
Type: Notice
Date: 2017-12-29
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.
Document Number: 2017-28177
Type: Notice
Date: 2017-12-29
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: ABBVIE LTD; Correction
Document Number: 2017-28176
Type: Notice
Date: 2017-12-29
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) published a document in the Federal Register of December 1, 2017, concerning a notice of application that inadvertently misstated what the firm plans to do with imported tapentadol.
Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related Substances in Schedule I
Document Number: 2017-28114
Type: Proposed Rule
Date: 2017-12-29
Agency: Drug Enforcement Administration, Department of Justice
The Administrator of the Drug Enforcement Administration is publishing this notice of intent to issue an order temporarily scheduling fentanyl-related substances that are not currently listed in any schedule of the Controlled Substances Act (CSA). The temporary order will place these substances in schedule I. This action is based on a finding by the Administrator that the placement of these synthetic opioids in schedule I is necessary to avoid an imminent hazard to the public safety. When it is issued, the temporary scheduling order will impose regulatory requirements under the CSA on the manufacture, distribution, reverse distribution, possession, importation, exportation, research, and conduct of instructional activities, and chemical analysis of these synthetic opioids, as well as administrative, civil, and criminal remedies with respect to persons who fail to comply with such requirements or otherwise violate the CSA with respect to these substances.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.